ADA2 Recombinant Antibody

$Lane 1: Human MOLT4 cell lysates; Lane 2: Human HUVEC cell lysates(Negative control) probed with ADA2 Monoclonal Antibody, Unconjugated (bsm-60919R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at room temperature for 60 min.$

Lane 1: Human MOLT4 cell lysates; Lane 2: Human HUVEC cell lysates(Negative control) probed with ADA2 Monoclonal Antibody, Unconjugated (bsm-60919R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at room temperature for 60 min.

Applications

Reactivity

Human

Overview
Catalog #	bsm-60919r
Product Name	ADA2 Recombinant Antibody
Applications	WB
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human ADA2
Clonality	Recombinant
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	51846
Swiss Prot	Q9NZK5
Subcellular location	Secreted
Synonyms	ADA2_HUMAN; Adenosine deaminase 2; Cat eye syndrome critical region protein 1; ADGF; CECR1; IDGFL;
Background	This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].
Application Dilution
WB	1:300-5000